Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression

Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression

Glioblastoma (GBM) is the most common and aggressive of all brain tumors, with a median survival of only 14 months after initial diagnosis. Novel therapeutic approaches are an unmet need for GBM treatment. MicroRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the p...

Full description

Bibliographic Details
Main Authors: Eunice L. Lozada-Delgado, Nilmary Grafals-Ruiz, Miguel A. Miranda-Román, Yasmarie Santana-Rivera, Fatma Valiyeva, Mónica Rivera-Díaz, María J. Marcos-Martínez, Pablo E. Vivas-Mejía
Format: Article
Language:English
Published: MDPI AG 2018-10-01
Series:Cancers
Subjects:
glioblastoma
microRNAs
mouse model
cell proliferation
Online Access:http://www.mdpi.com/2072-6694/10/10/382

Internet

http://www.mdpi.com/2072-6694/10/10/382

Similar Items